Consort Medical PLC's ticker is and the CUSIP is G2506K103. A total of 1 filers reported holding Consort Medical PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $303,000 | -12.2% | 32,670 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $345,000 | -7.5% | 32,670 | 0.0% | 0.00% | -20.0% |
Q1 2019 | $373,000 | -4.4% | 32,670 | 0.0% | 0.01% | -16.7% |
Q4 2018 | $390,000 | -23.1% | 32,670 | 0.0% | 0.01% | -14.3% |
Q3 2018 | $507,000 | -1.4% | 32,670 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $514,000 | +0.2% | 32,670 | 0.0% | 0.01% | +16.7% |
Q1 2018 | $513,000 | -0.6% | 32,670 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $516,000 | +8.4% | 32,670 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $476,000 | +7.0% | 32,670 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $445,000 | +5.0% | 32,670 | 0.0% | 0.01% | +20.0% |
Q1 2017 | $424,000 | -0.7% | 32,670 | 0.0% | 0.01% | -16.7% |
Q4 2016 | $427,000 | -7.0% | 32,670 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $459,000 | +1.1% | 32,670 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $454,000 | -10.1% | 32,670 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $505,000 | -9.2% | 32,670 | 0.0% | 0.01% | -14.3% |
Q4 2015 | $556,000 | +20.3% | 32,670 | 0.0% | 0.01% | +40.0% |
Q3 2015 | $462,000 | -1.1% | 32,670 | 0.0% | 0.01% | 0.0% |
Q2 2015 | $467,000 | +12.0% | 32,670 | 0.0% | 0.01% | +25.0% |
Q1 2015 | $417,000 | -5.4% | 32,670 | 0.0% | 0.00% | -33.3% |
Q4 2014 | $441,000 | -14.2% | 32,670 | 0.0% | 0.01% | +20.0% |
Q3 2014 | $514,000 | -3.6% | 32,670 | 0.0% | 0.01% | 0.0% |
Q2 2014 | $533,000 | +4.5% | 32,670 | 0.0% | 0.01% | 0.0% |
Q1 2014 | $510,000 | -51.1% | 32,670 | -50.4% | 0.01% | -50.0% |
Q4 2013 | $1,044,000 | +12.5% | 65,851 | 0.0% | 0.01% | 0.0% |
Q3 2013 | $928,000 | -16.3% | 65,851 | -25.0% | 0.01% | -23.1% |
Q2 2013 | $1,109,000 | – | 87,851 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCHAFER CULLEN CAPITAL MANAGEMENT INC | 65,851 | $1,044,000 | 0.01% |